Gynocular + T2D: A Global Vision for Gold-Standard Cervical Screening.
Global Joint Venture Impact (India, Philippines, Peru, Dominican Republic)
Interested in partnering with us? Discover the full features and capabilities of the Gyneye Digital Colposcope.
A shared commitment to accessible, high-quality healthcare brought Gynocular and their partners together in Stockholm, Sweden. They created the Triage to Diagnose (T2D) – the first FDA-approved cloud-based colposcopy and EHR application.
This global initiative proves that cutting-edge med-tech, when designed for equity, can bridge healthcare gaps and save lives, regardless of geography or income level.
Gyneye smart colposcope is a simple and intuitive design that offers healthcare and research organisations to reach out to populations and triage patients based on screening of cervical cancer, severity of the disease in shortest time and with great success.
Copyright © 2025 All Rights Reserved.
